CEREZYME
CEREZYME
Discontinued
DIN Number
02230694
Drug Class
Human
Market Date
Apr 30, 1997
Company
HC
sanofi genzyme, a division of sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230694
AIG Number0131511001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A16AB02 IMIGLUCERASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IMIGLUCERASEActive
Strength: 200 UNIT / VIAL
Monograph: IMIGLUCERASE